New tools aim to help women with diabetes plan safer pregnancies
NCT ID NCT04976881
First seen Jun 27, 2026 · Last updated Sep 11, 2026 · Updated 3 times
Summary
This study is testing two simple tools to help women with type 2 diabetes better manage their condition and understand reproductive health risks. The tools include a personalized medication list for patients and an alert for doctors during checkups. Researchers will track blood sugar, blood pressure, and knowledge about pregnancy risks in 840 women aged 18-44 who are not currently pregnant.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- behavioral intervention (medication review tool and provider alert system)
- What this could lead to
- If successful, this could give doctors and patients simple, practical tools to improve diabetes control and reproductive health awareness in women of childbearing age.
- What could go wrong
- This is a behavioral study, not a drug trial, so the impact may be modest. Results depend on how well patients and providers follow the tools, and the study is still recruiting.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 840 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2022
- Expected to finish
-
Apr 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 44 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * female * age 18-44 * English or Spanish-speaking * have a chart diagnosis of type 2 diabetes * not currently pregnant * not infecund, sterilized, or in a monogamous relationship with a sterilized partner * have a private cell phone with text messaging capability. Exclusion Criteria: * severe, uncorrectable vision, hearing, or cognitive impairments that would preclude study consent or participation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Diabetes mellitus type 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Northwestern University
Chicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a text message save lives in a heat wave?
- Can a nurse and a neighbor help tame chronic disease?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Can a vegan diet shield police officers from heart disease?
- Can a health coach in your patient portal help you lose weight?
- Common antibiotic may boost diabetes control